Digital Health Startups
6,443 companies tagged Digital Health, with their investors and founders.
Nanostics is a precision health company developing non-invasive diagnostic tests and medical devices that use machine learning to detect and assess aggressive cancers such as prostate cancer, aiming to improve diagnosis and healthcare decisions. It serves clinicians and patients in the cancer diagnostics field.
2 investors
Narrable Health provides an AI platform for home health agencies that automates administrative and clinical documentation work, including AI-generated OASIS notes, compliance QA, billing, and referral growth. It serves home health organizations across roles such as executives, directors of nursing, operations, and finance.
2 investors
Navitas Life Sciences is a contract research organization (CRO) offering advisory, clinical development, and post-marketing services for pharmaceutical, biotech, medical device, and non-profit organizations. Its work covers regulatory compliance, clinical operations, data sciences, pharmacovigilance, and real-world evidence across the drug development lifecycle.
2 investors
Navi develops a medical device — an ECG-based catheter tip location system for newborn and pediatric patients — to help doctors and nurses in neonatal and pediatric intensive care units deliver better vascular access care. The company works with clinicians internationally to improve pediatric patient outcomes.
2 investors
2 investors
NeoDocs provides at-home health assessment tests with lab-quality accuracy and personalized health monitoring for consumers seeking preventive wellness. The company focuses on proactive health optimization rather than disease treatment.
2 investors
Neteera develops contactless sensor-based technology for continuous patient monitoring, using AI and signal processing to support clinical workflows and remote care. It sells to healthcare providers, including in the North American market.
2 investors
Network Bio activates biobanks through securitization and capital infusion, providing research-grade data assets and operational infrastructure for precision medicine and biomedical research.
2 investors
Neuro Event Labs makes Nelli, a video/audio-based seizure monitoring system that uses machine learning to detect and analyze motor seizures for epilepsy patients at home and in the hospital. It provides a web-based dashboard with AI-generated, physician-reviewed reports, and is regulated as a Class IIa medical device in the EU and UK and cleared as a medical device in the US.
2 investors
neurocare group operates a network of over 20 clinics across Europe, the United States, and Australia offering personalized mental health treatments such as TMS, neurofeedback, and tDCS for conditions including depression, ADHD, OCD, and sleep disorders. It also provides a Digital Therapy Platform and an online academy that trains third-party clinicians in its treatment protocols.
2 investors
Neurode develops a wearable neurostimulation headband paired with a companion app that provides personalized insights and recommendations from psychologists, neuroscientists, and engineers. The device uses clinical-grade stimulation pads and targets adults in the US managing mental health and neurological wellness.
2 investors
NeuroFlow provides behavioral health risk analytics, engagement, and referral infrastructure that use machine learning on claims, EHR, ADT, and assessment data to identify and stratify behavioral health needs across populations. It serves payors, health systems, and the federal government to connect members and patients to appropriate care and measure outcomes for cost control and quality performance.
2 investors
Neuroglee provides memory and dementia care programs, including support for care partners, delivered through value-based arrangements. It partners with value-based provider groups, health insurance plans, and other risk-bearing organizations to deliver evidence-based dementia care.
2 investors
Neuronostics develops BioEP, software that applies digital analysis of background EEG to generate biomarkers supporting epilepsy diagnosis for clinicians and neurology services. The product aims to make epilepsy diagnostics more efficient and enable earlier, more accurate diagnoses.
2 investors
NeuroSonic develops a handheld, non-invasive device that assesses stroke risk by analyzing carotid artery blood flow, enabling clinicians to determine which patients require further vascular imaging. The device is designed for use in clinical settings to accelerate stroke-risk assessment and improve prevention.
2 investors
Neurosynaptic Communications develops the ReMeDi platform, a digital health solution combining point-of-care diagnostics, cloud-based healthcare management, and telemedicine technology for affordable healthcare access in rural and remote areas. The company serves underserved communities across Asia, Africa, and the US through partnerships with foundations and healthcare organizations.
2 investors
NeuroWyzr is a clinical neuroscience company that builds gamified digital assessments and care products for early detection, diagnosis, monitoring and prevention of brain decline. Its offerings use clinical evidence and AI-powered analytics to support brain health and mental wellbeing, with a focus on the Asia-Pacific market.
2 investors
Nevro develops spinal cord stimulation (SCS) systems for the treatment of chronic pain, including FDA-approved indications for painful diabetic neuropathy and non-surgical back pain. Its offerings are aimed at physicians and patients seeking long-term chronic pain relief.
2 investors
NewDays offers a clinician-supervised cognitive treatment program combining telehealth support with AI-guided brain training exercises, designed for individuals with mild cognitive impairment or dementia. The program is delivered at home and aims to improve cognitive function, mental health, and delay symptom progression.
2 investors
Newton's Tree is an AI orchestration and deployment platform for hospitals that helps health systems select, test, deploy, and monitor AI products as managed infrastructure. It offers a vendor-neutral AI marketplace, sandbox performance testing, workflow integration via standards like DICOM, HL7v2, and FHIR, and continuous monitoring, serving health systems across the US, UK, and Europe.
2 investors
Nexleaf Analytics develops sensor-based IoT technologies and data systems that help health workers monitor, maintain, and repair medical equipment such as vaccine cold chain refrigerators in lower-resource countries. It works with Ministries of Health across Africa and Asia to build country-owned, responsive data systems that protect vaccine supplies.
2 investors
Next Health operates wellness clinics offering IV vitamin therapy, NAD+ drips, peptide therapy, and bioidentical hormone optimization delivered through in-lounge sessions and membership plans. It serves consumers focused on longevity and health optimization, with locations in cities including West Hollywood, Century City, Studio City, New York City, Nashville, and Maui.
2 investors
Nicolab builds StrokeViewer, an AI-powered, cloud-based platform for acute care teams that speeds up stroke triage by giving physicians fast access to DICOM imaging, patient timelines, and secure messaging across hospitals. It serves clinicians such as neuroradiologists in the stroke care workflow, with detection support for occlusions (LVO) and intracranial hemorrhage.
2 investors
nilo offers workplace mental health support, connecting employees and leaders with psychologists for sessions, coaching, roundtables, and digital exercises. It sells to companies as a benefit aimed at improving company culture, engagement, and talent retention.
2 investors